Read, Andrew;
Akodu, Jane;
Barber, Tristan;
Brown, James;
Burns, Fiona;
Hurst, John;
Miller, Robert;
(2025)
Chronic Obstructive Pulmonary Disease in People with HIV: an Evidence-Based Review.
HIV/AIDS - Research and Palliative Care
, 17
pp. 153-174.
10.2147/hiv.s496211.
Preview |
Text
Miller_HIV-496211-chronic-obstructive-pulmonary-disease-in-people-with-hiv--an.pdf Download (3MB) | Preview |
Abstract
HIV co-infection is a risk factor for the development of COPD. HIV enhances the deleterious effects of exposures such as tobacco smoking, as well as interacting with other drivers of COPD such as pulmonary tuberculosis, air pollution and biomass fuel burning. Recent work demonstrates that HIV also contributes independently to COPD pathogenesis by promoting oxidative stress, chronic inflammation, abnormal innate and adaptive immune responses, microbial dysbiosis, and epigenetic alterations within the lung. Consequently, people with HIV develop COPD younger, more often, and with faster rates of lung function decline compared to seronegative individuals. They may also have distinct patterns of lung function abnormalities compared to other etiotypes of COPD. Understanding the natural and pathogenetic history of HIV-associated COPD is important as its assessment, prevention and treatment are currently extrapolated from the general population. Whilst smoking cessation remains vital, further understanding may help guide unique management strategies for HIV-associated COPD. In this review, we explore its epidemiology and pathophysiology and discuss prevention and treatment approaches in this increasingly common disease.
Type: | Article |
---|---|
Title: | Chronic Obstructive Pulmonary Disease in People with HIV: an Evidence-Based Review |
Open access status: | An open access version is available from UCL Discovery |
DOI: | 10.2147/hiv.s496211 |
Publisher version: | https://doi.org/10.2147/hiv.s496211 |
Language: | English |
Additional information: | © 2025 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, 4.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms. |
Keywords: | Smoking, emphysema, lung function, airflow obstruction, air pollution, antiretroviral therapy |
UCL classification: | UCL UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Div of Medicine UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences > Institute for Global Health UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Div of Medicine > Respiratory Medicine |
URI: | https://discovery.ucl.ac.uk/id/eprint/10209833 |
Archive Staff Only
![]() |
View Item |